ATE108022T1 - Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc. - Google Patents

Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.

Info

Publication number
ATE108022T1
ATE108022T1 AT86906660T AT86906660T ATE108022T1 AT E108022 T1 ATE108022 T1 AT E108022T1 AT 86906660 T AT86906660 T AT 86906660T AT 86906660 T AT86906660 T AT 86906660T AT E108022 T1 ATE108022 T1 AT E108022T1
Authority
AT
Austria
Prior art keywords
arc
aids
composition
vaccination
ligand
Prior art date
Application number
AT86906660T
Other languages
English (en)
Inventor
Ronald C Kennedy
Gordon R Dreesman
Myron Essex
Original Assignee
Southwest Found Biomed Res
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest Found Biomed Res, Harvard College filed Critical Southwest Found Biomed Res
Application granted granted Critical
Publication of ATE108022T1 publication Critical patent/ATE108022T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86906660T 1985-10-24 1986-10-22 Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc. ATE108022T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79083085A 1985-10-24 1985-10-24

Publications (1)

Publication Number Publication Date
ATE108022T1 true ATE108022T1 (de) 1994-07-15

Family

ID=25151854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86906660T ATE108022T1 (de) 1985-10-24 1986-10-22 Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.

Country Status (6)

Country Link
EP (1) EP0245362B1 (de)
JP (1) JPS63501716A (de)
AT (1) ATE108022T1 (de)
CA (1) CA1305828C (de)
DE (1) DE3689941D1 (de)
WO (1) WO1987002775A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2625100A2 (fr) * 1986-03-13 1989-06-30 Lurhuma Zirimwabagabo Utilisation d'antigenes pour la preparation de vaccins, proteine rendue immunogene et composition pharmaceutique la comportant
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
ATE96450T1 (de) * 1986-06-03 1993-11-15 Us Commerce Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
EP0366718B1 (de) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Hiv-1 neutralisierende monoklonale antikörper
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
US5013548A (en) * 1987-09-08 1991-05-07 Duke University Production of antibodies to HIV
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.
EP0346343B1 (de) * 1987-12-19 1993-02-03 Ao-Forschungsinstitut Davos Antivirales therapeutikum
WO1989005820A1 (en) * 1987-12-21 1989-06-29 Arch Development Corporation Hiv-related antigens and antibodies
WO1989005821A1 (en) * 1987-12-21 1989-06-29 Arch Development Corporation Hiv-related antigens and antibodies
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
JP2569185B2 (ja) * 1988-01-26 1997-01-08 アメリカ合衆国 抗ｈｉｖ応答を喚起する合成抗原
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
AU3538689A (en) * 1988-04-07 1989-11-03 Trustees Of The University Of Alabama, The Peptides inhibitors of hiv induced cell fusions and syncytia formation
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
IT1226552B (it) * 1988-07-29 1991-01-24 Ellem Ind Farmaceutica Peptidi immunostimolanti.
EP0362909A3 (de) * 1988-08-26 1990-11-14 Akzo N.V. Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern
IL91843A0 (en) * 1988-10-03 1990-06-10 Repligen Corp Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
ATE135113T1 (de) * 1988-12-20 1996-03-15 Clarity Technologies Inc Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
JP3115596B2 (ja) * 1990-08-22 2000-12-11 トリペプ アクチボラゲット ヒト免疫不全ウィルス感染を阻止するペプチドとその使用法
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
WO2000039302A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1035219A1 (de) * 1999-02-25 2000-09-13 Universiteit Gent Gastrische Helicobacter 16S-rDNA Sequenzen von Rind und Schwein und ihre Anwendung zur Detektion and Typisierung von Helicobacter Stämmen
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2458995C (en) 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2006261133B2 (en) * 2005-06-23 2012-04-05 Rapid Pharmaceuticals Ag Therapeutic peptides and vaccines
CN111982615A (zh) * 2019-05-23 2020-11-24 百奥泰生物制药股份有限公司 一种用于解离药物/ada复合物的解离液及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
KR930000189B1 (ko) * 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
EP0227169B1 (de) * 1985-12-17 1993-03-17 Akzo N.V. Immunochemisches Reagenz

Also Published As

Publication number Publication date
DE3689941D1 (de) 1994-08-04
EP0245362B1 (de) 1994-06-29
CA1305828C (en) 1992-07-28
EP0245362A1 (de) 1987-11-19
JPS63501716A (ja) 1988-07-14
WO1987002775A1 (en) 1987-05-07
EP0245362A4 (de) 1990-04-10

Similar Documents

Publication Publication Date Title
DE3689941D1 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
Lewis et al. C-type viruses in systemic lupus erythematosus
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DE68929467T2 (de) HIV-2 Varianten
Hierholzer et al. Protein composition of coronavirus OC 43
Yoshiki et al. Common cell surface antigen associated with mammalian C-type RNA viruses: cell membrane-bound gs antigen
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
IL209116A0 (en) Pharmaceutical compositions and vaccines comprising an antigenic portion of a chlamydia protein, and uses thereof
ATE99330T1 (de) Rekombinantes viren-ueberzugsprotein assoziiert mit ''acquired immune deficiency syndrome'' (aids) und verfahren zur testung von aids.
EP2192128A3 (de) Verbindungen und Verfahren zur Behandlung und Diagnose von Chlamydia-Infektionen
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
Obinata et al. Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle
NO885090D0 (no) Polypeptider.
SE8900899L (sv) Peptider foer diagnostisk anvaendning
ATE269904T1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
EP0834567A3 (de) Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Babesia microti Infektion
ATE76974T1 (de) Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
Suzuki et al. Anisakiasis: preparation of a stable antigen for indirect fluorescent antibody test
DE3939470A1 (de) Peptide und antikoerper gegen peptide, welche zur diagnose und zur verhuetung der b19-infektion verwendbar sind
Paulin et al. Immunochemical procedure for partial purification of newly synthesized proteins in polyoma virus-infected mouse cells
JPWO2009014207A1 (ja) 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原
Thomas et al. The use of immunochemically purified anti-brucella antibody in a direct fluorescent antibody test for Brucella abortus

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties